High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass

Journal of Anesthesia

Volumn 26, Issue 1, 2012, Pages 9-19

  Ogawa, Satoru ^a   Sakai, Tetsuro ^b   Richardson, James E ^a   Ide, Masahiro ^b   Tanaka, Kenichi A ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c Anesthesia Associates of Kobe   (Japan)

Author keywords

Antithrombin; Cardiopulmonary bypass; Intracardiac thrombosis; Intrapulmonary thrombosis; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN; APROTININ; CAPROLACTAM; HEPARIN; HIRULOG; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DRUG EFFICACY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEMOSTASIS; HEPARINIZATION; HUMAN; HYPOTENSION; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; LUNG INFARCTION; MALE; MEDICAL LITERATURE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART DISEASE; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

ADULT; AGED; CARDIOPULMONARY BYPASS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84862241763     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-011-1253-x     Document Type: Article

References (74)

1. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001;134:224-38. (Pubitemid 32113325)
2. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999;91:1122-51. (Pubitemid 29466546)
3. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, Saggau W. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost. 2005;93: 1101-7. (Pubitemid 40823515)
4. Ide M, Bolliger D, Taketomi T, Tanaka KA. Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth. 2010;24:96-106.
5. Green JA, Spiess BD. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin N Am. 2003;21:527-51. (Pubitemid 37169543)
6. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773-81. (Pubitemid 32429746)
7. Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. Anesth Analg. 2007;104:763-5. (Pubitemid 46548293)
8. Kohler M, Hellstern P, Lechler E, Uberfuhr P, Muller-Berghaus G. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost. 1998;80:399-402. (Pubitemid 28438732)
9. Heindl B, Delorenzo C, Spannagl M. High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist. 2005;54:787-90. (Pubitemid 41223786)
10. Warnaar N, Molenaar IQ, Colquhoun SD, Slooff MJH, Sherwani S, de Wolf AM, Porte RJ. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. J Thromb Haemost. 2008;6:297-302.
11. Augoustides JG. Fatal intraoperative thrombosis in contemporary adult thoracic aortic surgery requiring deep hypothermic circulatory arrest: observations from the literature, 1993-2006. J Thorac Cardiovasc Surg. 2007;134:1069-70. (Pubitemid 47454623)
12. Augoustides JG. Fatal thrombosis in complex cardiac surgery without deep hypothermic circulatory arrest in the setting of standard-of-care heparinization: status quo and directions for further research. J Thorac Cardiovasc Surg. 2007;134:1053-4. (Pubitemid 47445620)
13. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791-800.
14. Umbrain V, Christiaens F, Camu F. Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated? J Cardiothorac Vasc Anesth. 1994;8:198-201. (Pubitemid 24118400)
15. Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg. 1998;116:716-30. (Pubitemid 28499166)
16. Chun R, Poon M-C, Haigh J, Seal D, Donahue B, Royston D. Case 1-2005: cardiac surgery in congenital afibrinogenemia with thrombo-occlusive disease. J Cardiothorac Vasc Anesth. 2005;19: 109-17. (Pubitemid 40254298)
17. Sundt TM 3rd, Kouchoukos NT, Saffitz JE, Murphy SF, Wareing TH, Stahl DJ. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg. 1993;55:1418-24. (Pubitemid 23189389)
18. Saffitz JE, Stahl DJ, Sundt TM, Wareing TH, Kouchoukos NT. Disseminated intravascular coagulation after administration of aprotinin in combination with deep hypothermic circulatory arrest. Am J Cardiol. 1993;72:1080-2. (Pubitemid 23319934)
19. Bui JD, Despotis GD, Trulock EP, Alexander Patterson G, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002;124:852-4. (Pubitemid 36025371)
20. Swaminathan M, Shaw AD, Greenfield RA, Grichnik KP. Fatal thrombosis after factor seven administration during extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2008; 22:259-60. (Pubitemid 351423683)
21. Lukauskis K, Banks D. Factor IX complex: help or harm? (abstract). In: 33rd Annual Meeting of Society of Cardiovascular Anesthesiologists in Savannah, GA, USA. 2011.
22. Apostolidou I, Sweeney MF, Missov E, Joyce LD, John R, Prielipp RC. Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia. Anesth Analg. 2008;106:404-8. (Pubitemid 351156660)
23. Lichtman AD, Carullo V, Minhaj M, Karkouti K. Case 6-2007: massive intraoperative thrombosis and death after recombinant activated factor VII administration. J Cardiothorac Vasc Anesth. 2007;21:897-902. (Pubitemid 350199632)
24. Gitter R, Alivizators P, Capehart J, Ramsay M, Jett GK. Aprotinin and aortic cannula thrombosis. J Thorac Cardiovasc Surg. 1996;112:537-8. (Pubitemid 26301867)
25. Alvarez JM, Goldstein J, Mezzatesta J, Flanagan B, Dodd M. Fatal intraoperative pulmonary thrombosis after graft replacement of an aneurysm of the arch and descending aorta in association with deep hypothermic circulatory arrest and aprotinin therapy. J Thorac Cardiovasc Surg. 1998;115:723-4. (Pubitemid 28158091)
26. Heindel SW, Mill MR, Freid EB, Valley RD, White GC, Norfleet EA. Fatal thrombosis associated with a hemi-Fontan procedure, heparin-protamine reversal, and aprotinin. Anesthesiology. 2001; 94:369-71. (Pubitemid 32125935)
27. Fanashawe MP, Shore-Lesserson L, Reich DL. Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. Anesthesiology. 2001;95:1525-7. (Pubitemid 33126768)
28. Ramsey MAE, Marcel RJ, Capehart J, Cheung EH, Ring WS. Massive intravascular thrombosis and thromboembolism after cardiopulmonary bypass. Internet J Thorac Cardiovasc Surg. 2003;5. http://www.ispub.com.
29. Lagare JF, AroraR, WoodJW.Massive intracavitary clot formation during cardiopulmonary bypass. Can J Cardiol. 2004;20:825-6. (Pubitemid 39089614)
30. Augoustides JGT, Lin J, Gambone AJ, Cheung AT. Fatal thrombosis in an adult after thoracoabdominal aneurysm repair with aprotinin and deep hypothermic circulatory arrest. Anesthesiology. 2005;103:215-6. (Pubitemid 40943161)
31. Augoustides JG, Kilbaugh T, Harris H, Glick JH, Acker M, Savino JS. Fatal thrombosis after mitral valve replacement for endocarditis: aprotinin and disseminated intravascular coagulation. Anesthesiology. 2006;104:213.
32. Shore-Lesserson L, Reich DL. A case of severe diffuse venous thromboembolism associated with aprotinin and hypothermic circulatory arrest in a cardiac surgical patient with factor V Leiden. Anesthesiology. 2006;105:219-21. (Pubitemid 44305212)
33. Kottenberg-Assenmacher E, Volbracht L, Jakob H, Greinacher A, Peters J. Disseminated intravascular clotting associated with Fc-receptor IIa-mediated platelet activation in a patient with endocarditis after aortic valve replacement. Br J Anaesth. 2006;97:630-3. (Pubitemid 44593856)
34. Schmitz A, Hartmann M. Acute intracardiac thrombus formation during thoracoabdominal aortic surgery. Anesth Analg. 2006; 102:1658-9. (Pubitemid 43799832)
35. Neira VM, Sawchuk C, Bonneville KS, Chu V, Warkentin TE. Case report: management of immediate post-cardiopulmonary bypass massive intra-cardiac thrombosis. Can J Anaesth. 2007; 54:461-6. (Pubitemid 46925268)
36. Trigo P, Stone M, Fisher G. A patient presenting for concurrent thoracoabdominal aortic aneurysm repair and left ventricular assist device placement (abstract). In: 33rd Annual Meeting of Society of Cardiovascular Anesthesiologists in Savannah, GA, USA. 2011.
37. Stone ME, Silverman SH, Nomoto K. Intracardiac thrombosis and acute right ventricular failure following complex reoperative cardiac surgery with aprotinin and deep hypothermic circulatory arrest. Semin Cardiothorac Vasc Anesth. 2007;11:177-84. (Pubitemid 47301104)
38. Cooper JR Jr, Abrams J, Frazier OH, Radovancevic R, Radovancevic B, Bracey AW, Kindo MJ, Gregoric ID. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg. 2006;131:963-8.
39. Donahue BS, Gailani D, Mast AE. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass. J Thromb Haemost. 2006;4:1011-6.
40. Journois D, Mauriat P, Pouard P, Marchot P, Amiral J, Safran D. Assessment of coagulation factor activation during cardiopulmonary bypass with a new monoclonal antibody. J Cardiothorac Vasc Anesth. 1994;8:157-61. (Pubitemid 24118393)
41. Boyle EM Jr, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg. 1996;62:1549-57. (Pubitemid 26383582)
42. Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg. 1997;113:576-84. (Pubitemid 27149142)
43. Sniecinski RM, Chen EP, Tanaka KA. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis. 2008;19:178-9. (Pubitemid 351252997)
44. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, Levy JH, Tanaka KA. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion. 2011. doi:10.1111/j.1537-2995.2011.03241.x
45. Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 1999;94:172-8. (Pubitemid 29300146)
46. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000;106:385-92. (Pubitemid 30655638)
47. Mosesson MW. Update on antithrombin I (fibrin). Thromb Haemost. 2007;98:105-8. (Pubitemid 47074184)
48. Hathcock JJ, Nemerson Y. Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood. 2004;104:123-7. (Pubitemid 38879847)
49. Elliott MA, Chen MG, Silverstein MN, Tefferi A. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Haematol. 1998;103: 505-11. (Pubitemid 28522460)
50. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood. 1991;77:542-50.
51. Raivio P, Fernandez JA, Kuitunen A, Griffin JH, Lassila R, Petaja J. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007; 133:44-51. (Pubitemid 46014242)
52. Sniecinski R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg. 2008;106: 713-8. (Pubitemid 351301383)
53. Maslow A, Lowenstein E, Steriti J, Leckie R, Cohn W, Haering M. Left ventricular thrombi: intraoperative detection by transesophageal echocardiography and recognition of a source of post CABG embolic stroke: a case series. Anesthesiology. 1998;89: 1257-62. (Pubitemid 28516554)
54. Planinsic RM, Nicolau-Raducu R, Eghtesad B, Marcos A. Diagnosis and treatment of intracardiac thrombosis during orthotopic liver transplantation. Anesth Analg. 2004;99:353-6. (Pubitemid 38970399)
55. Jackson D, Botea A, Gubenko Y, Delphin E, Bennett H. Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/ pulmonary thrombosis. Anesth Analg. 2006;102:724-8.
56. Krishnamurti C, Vukelja SJ, Alving BM. Inhibitory effects of lysine analogues on t-PA induced whole blood clot lysis. Thromb Res. 1994;73:419-30. (Pubitemid 24094574)
57. Stassen JM, Lambeir AM, Matthyssens G, Ripka WC, Nystrom A, Sixma JJ, Vermylen J. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties. Thromb Haemost. 1995;74:646-54.
58. Diamond SL, Anand S. Inner clot diffusion and permeation during fibrinolysis. Biophys J. 1993;65:2622-43. (Pubitemid 24005994)
59. Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, Spitznagel E, Weitz JI, Goodnough LT. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996; 76:902-8. (Pubitemid 27013627)
60. Avidan MS, Levy JH, Van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;130:107-13. (Pubitemid 40941676)
61. Huyzen RJ, van Oeveren W, Wei F, Stellingwerf P, Boonstra PW, Gu YJ. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass. Ann Thorac Surg. 1996;62:533-7. (Pubitemid 26259700)
62. Casbard AC, Williamson LM, Murphy MF, Rege K, Johnson T. The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review. Anaesthesia. 2004;59:550-8. (Pubitemid 38744889)
63. Demeyere R, Gillardin S, Arnout J, Strengers PF. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang. 2010;99: 251-60.
64. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A, Stafford-Smith M, Waters J, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944-82.
65. Ryan DH, Crowther MA, Ginsberg JS, Francis CW. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med. 1998;128: 270-6. (Pubitemid 28090757)
66. Wahlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost. 2002;87:580-5. (Pubitemid 34302944)
67. Donahue BS. Factor V Leiden and perioperative risk. Anesth Analg. 2004;98:1623-34. (Pubitemid 38678619)
68. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585-93. (Pubitemid 28144815)
69. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood. 2005;105:2294-9. (Pubitemid 40387022)
70. Tanaka K, Szlam F, Katori N, Sato N, Vega J, Levy J. The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg. 2004;99:1283-9. (Pubitemid 39407269)
71. Tanaka KA, Szlam F, Vinten-Johansen J, Cardin AD, Levy JH. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan. Thromb Haemost. 2005;94:808-13. (Pubitemid 41489242)
72. Mangano DT, Tudor IC, Dietzel C, Multicenter Study of Perioperative Ischemia Research G, Ischemia Research and Education F. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353-65. (Pubitemid 43145060)
73. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R, Investigators B. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319-31. (Pubitemid 351749156)
74. Stein PD, Kayali F, Olson RE, Milford CE. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med. 2004;116: 435-42. (Pubitemid 38388612)